نتایج جستجو برای: vaccine delivery

تعداد نتایج: 310743  

Journal: :Frontiers in Drug Delivery 2022

SPECIALTY GRAND CHALLENGE article Front. Drug. Deliv., 11 July 2022Sec. Vaccine Delivery https://doi.org/10.3389/fddev.2022.964298

2014
Danielle Mazza Katja Petrovic Cathy Grech Naomi Harris

BACKGROUND Although the Human Papillomavirus (HPV) vaccine is registered in Australia for females aged 9 to 45 years, females aged 27 to 45 years have shown limited vaccine uptake. Our study explored general practitioners' (GPs) views concerning HPV vaccination of females in this age group, with particular focus on the barriers and the facilitators to the delivery of the HPV vaccine. METHODS ...

2015
Ying Pan Xiaopeng Li Tianyi Kang Hui Meng Zhouli Chen Li Yang Yang Wu Yuquan Wei Maling Gou

Some pathogens can be naturally recognized and internalized by antigen presentation cells (APCs) in vivo, providing a platform for efficient vaccine delivery. However, the biosafety concerns discourage the clinical applications of live pathogens. Here, yeast-derived microparticles were prepared for cancer vaccine delivery. By chemical treatment of bread yeast, capsular yeast shell (YS) micropar...

Farmoudeh, Ali, Rezaeiroshan, Anahita , Saeedi, Majid,

Transdermal patches are now widely used in topical and transdermal drug delivery systems (TDDS). Up to now, TDDS has been used in several conditions, such as smoking cessation, analgesic effect, nausea, contraception, and hormone therapy. Basically, there are two types of transdermal patches: the reservoir-type patches and the matrix-type patches. First generation TDDS were designed for deliver...

2016
Ru Wen Afoma C. Umeano Lily Francis Nivita Sharma Smanla Tundup Shanta Dhar

Vaccination is one of the most popular technologies in disease prevention and eradication. It is promising to improve immunization efficiency by using vectors and/or adjuvant delivery systems. Nanoparticle (NP)-based delivery systems have attracted increasing interest due to enhancement of antigen uptake via prevention of vaccine degradation in the biological environment and the intrinsic immun...

2014
Shantanu K. Kar Binod Sah Bikash Patnaik Yang Hee Kim Anna S. Kerketta Sunheang Shin Shyam Bandhu Rath Mohammad Ali Vittal Mogasale Hemant K. Khuntia Anuj Bhattachan Young Ae You Mahesh K. Puri Anna Lena Lopez Brian Maskery Gopinath B. Nair John D. Clemens Thomas F. Wierzba

INTRODUCTION The substantial morbidity and mortality associated with recent cholera outbreaks in Haiti and Zimbabwe, as well as with cholera endemicity in countries throughout Asia and Africa, make a compelling case for supplementary cholera control measures in addition to existing interventions. Clinical trials conducted in Kolkata, India, have led to World Health Organization (WHO)-prequalifi...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2008
Max Corbett Willy M Bogers Jonathan L Heeney Stefan Gerber Christian Genin Arnaud Didierlaurent Herman Oostermeijer Rob Dubbes Gerco Braskamp Stéphanie Lerondel Carmen E Gomez Mariano Esteban Ralf Wagner Ivanella Kondova Petra Mooij Sunita Balla-Jhagjhoorsingh Niels Beenhakker Gerrit Koopman Sjoerd van der Burg Jean-Pierre Kraehenbuhl Alain Le Pape

Each year, approximately five million people die worldwide from putatively vaccine-preventable mucosally transmitted diseases. With respect to mass vaccination campaigns, one strategy to cope with this formidable challenge is aerosol vaccine delivery, which offers potential safety, logistical, and cost-saving advantages over traditional vaccination routes. Additionally, aerosol vaccination may ...

Journal: :The American journal of tropical medicine and hygiene 2006
Guy Hutton Fabrizio Tediosi

This report presents an approach to costing the delivery of a malaria vaccine through the expanded program on immunization (EPI), and presents the predicted cost per dose delivered and cost per fully immunized child (FIC) in Tanzania, which are key inputs to the cost-effectiveness analysis. The costs included in the analysis are those related to the purchase of the vaccine taking into account t...

2015
douGlas C. eCkery roBert J. warren

Immunocontraceptive vaccines have shown some promise for fertility control of white-tailed deer (Odocoileus virginianus) in urban and suburban habitats where traditional methods of population control may not be applicable. Currently, the only contraceptive vaccine approved by the U.S. Environmental Protection Agency for use in white-tailed deer is GonaConTM Immunocontraceptive Vaccine, but it i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید